tm logo

Trademark Search

Owners

Gilead Sciences Ireland UC

DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS

DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Live/Registered
REGISTERED

on 13 Jul 2021

Last Applicant/ Owned by

IDA Business and Technology Park

Carrigtohill, Co. Cork

IE

Serial Number

88615918 filed on 13th Sep 2019

Registration Number

6414007 registered on 13th Jul 2021

in the Principal Register

Correspondent Address

Gretchen R. Stroud

GILEAD SCIENCES, INC.

333 LAKESIDE DRIVE

FOSTER CITY, CA 94404

Filing Basis

1. intent to use

Disclaimer

"EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS"

DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS

The mark consists of a blue diamond with an incomplete light blue diamond below it along with the word "DESCOVY" in blue to the right and the words "EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS" in black beneath "DESCOVY". Appearing below is the stylized wording "FOR PREP PRE-EXPOSURE PROPHYLAXIS" with the wording "FOR" and "PRE-EXPOSURE PROPHYLAXIS" in light blue, and the word "PREP"Read More

Classification Information


Class [005]
Pharmaceutical Products


Anti-viral pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of infectious diseases; pharmaceutical preparations for the treatment of immune dysfunction; pharmaceutical preparations for the treatment and prevention of human immunodeficiency virus infection; all of the foregoing containing emtricitabine and tenofovir alafenamide

Class [044]
Medical, Beauty & Agricultural Services


Information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, namely, pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, namely, pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services provided on-line over a computer network and the Internet; providing medical information and advisory services regarding HIV infection

Mark Details


Serial Number

No 88615918

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

10.09.01 -

Medicines and nonmedical products in tablet, capsule or powder form; suppositories

26.07.03 -

Incomplete diamonds or divided in the middle

26.07.13 -

Two diamonds

26.07.21 -

Diamonds that are completely or partially shaded

26.11.26 -

Oblongs as carriers for words, letters or designs

Description of Design Search

The mark consists of a blue diamond with an incomplete light blue diamond below it along with the word "DESCOVY" in blue to the right and the words "EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS" in black beneath "DESCOVY". Appearing below is the stylized wording "FOR PREP PRE-EXPOSURE PROPHYLAXIS" with the wording "FOR" and "PRE-EXPOSURE PROPHYLAXIS" in light blue, and the word "PREP" contained within a blue oblong shaped pill design. All instances of the color white in the mark represent background and/or transparent areas only and are not features of the mark.

Legal History


Show more

Status DateAction Taken
13th Jul 2021REGISTERED-PRINCIPAL REGISTER
04th Jun 20211(B) BASIS DELETED; PROCEED TO REGISTRATION
04th Jun 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
03rd May 2021NOTICE OF ALLOWANCE CANCELLED
03rd May 2021TEAS DELETE 1(B) BASIS RECEIVED
29th Dec 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03rd Nov 2020PUBLISHED FOR OPPOSITION
03rd Nov 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14th Oct 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29th Sep 2020ELECTRONIC RECORD REVIEW COMPLETE